Darunavir/ritonavir monotherapy in clinical practice

被引：1
|
作者：
Parienti, Jean-Jacques [1 ,2 ,3 ]
机构：
[1] Caen Cote de Nacre Univ Hosp, Dept Infect Dis & Clin Res & Biostat, Caen, France
[2] Univ Paris 06, Paris, France
[3] INSERM, UMR S 707, Paris, France
来源：
AIDS | 2011年 / 25卷 / 01期
关键词：
INDINAVIR;
D O I：
10.1097/QAD.0b013e3283405d2c
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [41] Interleukin-6 and C-reactive protein levels after 3 years of treatment with darunavir/ritonavir monotherapy or darunavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in the MONET trial
    Arribas, Jose
    Hill, Andrew
    Xi, Ning
    van Delft, Yvon
    Moecklinghoff, Christiane
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (07) : 1804 - 1806
  • [42] Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study
    Mandelbrot, Laurent
    Tubiana, Roland
    Frange, Pierre
    Peytavin, Gilles
    Le Chenadec, Jerome
    Canestri, Ana
    Morlat, Philippe
    Brunet-Cartier, Cecile
    Sibiude, Jeanne
    Peretti, Delphine
    Chambrin, Veronique
    Chabrol, Amelie
    Bul, Eida
    Simon-Toulza, Caroline
    Marchand, Lucie
    Paul, Christelle
    Delmas, Sandrine
    Avettand-Fenoel, Veronique
    Warszawski, Josiane
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (07) : 1711 - 1722
  • [43] Interaction of Rifampin and Darunavir-Ritonavir or Darunavir-Cobicistat In Vitro
    Roberts, Owain
    Khoo, Saye
    Owen, Andrew
    Siccardi, Marco
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (05)
  • [44] Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients
    Podzamczer, D.
    Imaz, A.
    Perez, I.
    Viciana, P.
    Valencia, E.
    Curto, J.
    Martin, T.
    Castano, M.
    Rojas, J.
    Espinosa, N.
    Moreno, V.
    Asensi, V.
    Iribarren, J. A.
    Clotet, B.
    Force, L.
    Bachiller, P.
    Knobel, H.
    Lopez Bernaldo De Quiros, J. C.
    Blanco, J. R.
    Rozas, N.
    Vergas, J.
    Ocampo, A.
    Camacho, A.
    Flores, J.
    Gomez-Sirvent, J. L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2536 - 2540
  • [45] Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 Substudy
    Valantin, M. A.
    Kolta, S.
    Flandre, P.
    Genin, M. Algarte
    Meynard, J. L.
    Ponscarme, D.
    Slama, L.
    Cuzin, L.
    de Kerviler, E.
    Inaoui, R.
    Katlama, C.
    HIV MEDICINE, 2012, 13 (08) : 505 - 515
  • [46] Monotherapy with lopinavir/ritonavir
    Schechter, Mauro
    Nunes, Estevao Portela
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (05) : 735 - 741
  • [47] Effectiveness of ritonavir-boosted protease inhibitor monotherapy in routine practice
    Fonquernie, L.
    Lefebvre, B.
    Valin, N.
    Morand-Joubert, L.
    Boyd, A.
    Meynard, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 155 - 155
  • [48] Management of Antiretroviral Therapy with Boosted Protease Inhibitors - Darunavir/Ritonavir or Darunavir/Cobicistat
    Marin, Ruxandra-Cristina
    Behl, Tapan
    Negrut, Nicoleta
    Bungau, Simona
    BIOMEDICINES, 2021, 9 (03)
  • [49] Therapeutic drug monitoring of darunavir/ritonavir in pregnancy
    Murtagh, Ross
    Else, Laura J.
    Kuan, Kenneth B. K.
    Khoo, Saye H.
    Jackson, Valerie
    Patel, Anjali
    Lawler, Marguerite
    McDonald, Grainne
    Le Blanc, David
    Avramovic, Gordana
    Redmond, Niamh
    Lambert, John S.
    ANTIVIRAL THERAPY, 2019, 24 (03) : 229 - 233
  • [50] Neuropsychiatric Adverse Events With Ritonavir-Boosted Darunavir Monotherapy in HIV-Infected Individuals: A Randomised Prospective Study
    Winston, Alan
    Faetkenheuer, Gerd
    Arribas, Jose
    Hill, Andrew
    van Delft, Yvon
    Moecklinghoff, Christiane
    HIV CLINICAL TRIALS, 2010, 11 (03): : 163 - 169
12345